Fundraising Fox
🦊/People
Sign in

Arthur Franken

Investor

General Partner - Healthtech/Therapeutics Venture&Growth at Gilde Healthcare · Board director at Moximed

The Netherlands

Find your path to Arthur

176 people in our graph share verified history with Arthur — schools, employers, funds. One of them is your warm intro.

Andrea van ElsasunlockedArthur: together at Leiden University (1994–1996)
×5Arthur: together at Leiden University
×3Arthur: together at Splice Bio
Arthur: together at STAT-Dx

About

Arthur Franken joined Gilde Healthcare in 2001 and helped launch the Venture&Growth strategy, overseeing investments in biopharmaceuticals, medtech, diagnostics, and digital health. He was previously a Research Fellow at the Leiden/Amsterdam Centre for Drug Research and TNO, and holds a Master's in Biopharmaceutical Sciences from Leiden University.

Contact· self-published, not guessed

Invests in

BiotechDigital HealthMedical Devices

Board director at Moximed

Intro paths

→

In turn, Arthur can intro founders to Moximed's investors below.

Moximed's investors · 8

Advent Life SciencesLondon · since 2024Future FundLondonGBS Venture Partners Ltd.Melbourne · $165K – $7.9M checksGilde HealthcareUtrecht · $1.1M – $55M checksLightstone VenturesPortola ValleyNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024Runway Growth CapitalMenlo Park · $10M – $150M checksVertex Ventures HCSingapore · $500K – $10M checks

Experience

  1. Gilde HealthcareGeneral Partner, Directorcurrent2020 — presentUtrecht, the Netherlands
  2. Gilde HealthcareInvestment Director, Partner2006 — 2019
  3. Gilde HealthcareInvestment Manager2004 — 2006
  4. Gilde HealthcareAssociate2001 — 2004
  5. SynOx TherapeuticsBoard membercurrent2025 — presentDublin, County Dublin, Ierland
  6. SpliceBioBoard Membercurrent2022 — presentBarcelona, Catalonië, Spanje
  7. Noema PharmaBoard Membercurrent2020 — present
  8. LEVICEPT LTDBoard Membercurrent2014 — presentDiscovery Park, Sandwhich, Kent, UK
  9. MoximedBoard Membercurrent2011 — presentHayward, California
  10. Purespring TherapeuticsPast Board member2024 — 2025
  11. Calypso BiotechPast Board Member2018 — 2024Geneva, Switzerland
  12. Breath Therapeutics, a Zambon companyPast Board Member2017 — 2019Munich Area, Germany
  13. SymphogenPast Board Observer2011 — 2018Pederstrupvej 93, 2750 Ballerup, Denmark
  14. STAT-DxPast Board Member2016 — 2018Barcelona, Catalonia, Spain
  15. ProQR TherapeuticsPast Board Member2014Leiden, the Netherlands
  16. mtm LaboratoriesPast Board Member2009 — 2011Heidelberg, Germany
  17. FlowCardiaPast Board Member2008 — 2010Sunnyvale, California, Verenigde Staten

Skills & more

Venture Capital32Venture Financing7Private Equity10Corporate Development14Growth Capital7Hardware Diagnostics2Orthopedic4M&A experienceLifesciences1Deal SourcingHealthcare14Deal Execution
+12 moreCapital RaisingBiotechnologyIPOPrivate PlacementsCancerMergersRestructuringMergers & AcquisitionsStrategyLife SciencesStart-upsBusiness Strategy

From Arthur's professional profile.

Colleagues at Gilde Healthcare

Besmire Ahmati
Senior Associate Investor Relations & Fundraising at Gilde Healthcare
Christiaan Sap
Operational Partner at Gilde Healthcare
Dirkjan Beugelsdijk
CFO at Gilde Healthcare
Edward Hanlon
Investment Director Venture&Growth at Gilde Healthcare
Edwin de Graaf
Managing Partner at Gilde Healthcare
Geoff Pardo
General Partner at Gilde Healthcare
Giel Modderman
Associate, Private Equity at Gilde Healthcare
Hugo de Bruin
General Partner at Gilde Healthcare

Frequently asked questions

Who is Arthur Franken?
Arthur Franken joined Gilde Healthcare in 2001 and helped launch the Venture&Growth strategy, overseeing investments in biopharmaceuticals, medtech, diagnostics, and digital health. He was previously a Research Fellow at the Leiden/Amsterdam Centre for Drug Research and TNO, and holds a Master's in Biopharmaceutical Sciences from Leiden University.
Where does Arthur Franken work?
Arthur Franken is General Partner - Healthtech/Therapeutics Venture&Growth at Gilde Healthcare and Board director at Moximed.
What does Arthur Franken invest in?
Arthur Franken invests in Biotech, Digital Health, Medical Devices.
Where did Arthur Franken go to school?
Arthur Franken studied at Leiden University (MSc, Biopharmaceutical Sciences); Lingecollege (VWO-B).

Same school

Shared employers